COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02RXJ
|
|||
Drug Name |
Ribavirin + lopinavir + ritonavir + interferon beta-1b
|
|||
Synonyms |
Tribavirin + Aluviran + norvir + betaseron
|
|||
Drug Type |
Combination drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2 | [1] | |
Therapeutic Class |
Antiviral Agents
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04276688) Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.